Definition
Autoinflammatory disorders are a varied group of diseases characterized by recurrent episodes of seemingly unprovoked inflammation, unlike the inflammatory reactions triggered in the course of infections or during the immune response to autoantigens. These disorders are sometimes termed “inflammasomopathies,” stemming from the central role that interleukin (IL)-1 plays in their pathogenesis (Horvath et al. 2011; Wilson and Cassel 2010; see section on Pathophysiology, below).
Fever is a major fixture in these disorders. Indeed, most of our knowledge of these disorders comes from studies done to understand the pathogenesis of the inherited periodic fever syndromes. However, fever is not a universal trait of these conditions – several syndromes are...
References
Aksentijevich, I., Galon, J., Soares, M., Mansfield, E., Hull, K., Oh, H. H., et al. (2001). The tumor-necrosis-factor receptor-associated periodic syndrome: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. American Journal of Human Genetics, 69, 301–314.
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., et al. (2009). An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. New England Journal of Medicine, 360, 2426–2437.
Baumgart, D. C., & Sandborn, W. J. (2012). Crohn’s disease. Lancet, 380, 1590–1605.
Braun-Falco, M., & Ruzicka, T. (2011). Skin manifestations in autoinflammatory syndromes. Journal der Deutschen Dermatologischen Gesellschaft, 9, 232–246.
Cochard, M., Clet, J., Le, L., Pillet, P., Onrubia, X., Gueron, T., et al. (2010). PFAPA syndrome is not a sporadic disease. Rheumatology (Oxford), 49, 1984–1987.
Contassot, E., Beer, H. D., & French, L. E. (2012). Interleukin-1, inflammasomes, autoinflammation and the skin. Swiss Medical Weekly, 142, w13590.
Drenth, J. P., & van Der Meer, J. W. (2001). Hereditary periodic fever. New England Journal of Medicine, 345, 1748–1757.
Feder, H. M., & Salazar, J. C. (2010). A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatrica, 99, 178–184.
Garavello, W., Pignataro, L., Gaini, L., Torretta, S., Somigliana, E., & Gaini, R. (2011). Tonsillectomy in children with periodic fever with aphthous stomatitis, pharyngitis, and adenitis syndrome. Journal of Pediatrics, 159, 138–142.
Glaser, R. L., & Goldbach-Mansky, R. (2008). The spectrum of monogenic autoinflammatory syndromes: Understanding disease mechanisms and use of targeted therapies. Current Allergy and Asthma Reports, 8, 288–298.
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., et al. (2006). Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. New England Journal of Medicine, 355, 581–592.
Goldfinger, S. E. (1972). Colchicine for familial Mediterranean fever. New England Journal of Medicine, 287, 1302.
Graham, W., & Roberts, J. B. (1953). Intravenous colchicine in the management of gouty arthritis. Annals of the Rheumatic Diseases, 12, 16–19.
Hoffman, H. M. (2009). Therapy of autoinflammatory syndromes. Journal of Allergy and Clinical Immunology, 124, 1129–1138.
Hoffmann, G. F., Charpentier, C., Mayatepek, E., Mancini, J., Leichsenring, M., Gibson, K. M., et al. (1993). Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics, 91, 915–921.
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., et al. (2008). Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis and Rheumatism, 58, 2443–2452.
Horvath, G. L., Schrum, J. E., De Nardo, C. M., & Latz, E. (2011). Intracellular sensing of microbes and danger signals by the inflammasomes. Immunology Reviews, 243, 119–135.
Houten, S. M., Frenkel, J., Rijkers, G. T., Wanders, R. J., Kuis, W., & Waterham, H. R. (2002). Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Human Molecular Genetics, 11, 3115–3124.
Houten, S. M., van Woerden, C. S., Wijburg, F. A., Wanders, R. J., & Waterham, H. R. (2003). Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. European Journal of Human Genetics, 11, 196–200.
Hull, K. M., Drewe, E., Aksentijevich, I., Singh, H. K., Wong, K., McDermott, E. M., et al. (2002). The TNF receptor-associated periodic syndrome (TRAPS): Emerging concepts of an autoinflammatory disorder. Medicine (Baltimore), 81, 349–368.
Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., et al. (2007). NALP1 in vitiligo-associated multiple autoimmune disease. New England Journal of Medicine, 356, 1216–1225.
Kolly, L., Busso, N., von Scheven-Gete, A., Bagnoud, N., Moix, I., Holzinger, D., et al. (2012). Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1beta production. Journal of Allergy and Clinical Immunology, 131, 1635–1643.
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., et al. (2009). Use of canakinumab in the cryopyrin-associated periodic syndrome. New England Journal of Medicine, 360, 2416–2425.
Lamkanfi, M., Walle, L. V., & Kanneganti, T. D. (2011). Deregulated inflammasome signaling in disease. Immunology Reviews, 243, 163–173.
Lobito, A. A., Kimberley, F. C., Muppidi, J. R., Komarow, H., Jackson, A. J., Hull, K. M., et al. (2006). Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood, 108, 1320–1327.
Mandey, S. H., Kuijk, L. M., Frenkel, J., & Waterham, H. R. (2006). A role for geranylgeranylation in interleukin-1beta secretion. Arthritis and Rheumatism, 54, 3690–3695.
Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 440, 237–241.
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., et al. (1999). Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 97, 133–144.
Miao, Z. M., Zhao, S. H., Yan, S. L., Li, C. G., Wang, Y. G., Meng, D. M., et al. (2009). NALP3 inflammasome functional polymorphisms and gout susceptibility. Cell Cycle, 8, 27–30.
Milhavet, F., Cuisset, L., Hoffman, H. M., Slim, R., El-Shanti, H., Aksentijevich, I., et al. (2008). The infevers autoinflammatory mutation online registry: Update with new genes and functions. Human Mutation, 29, 803–808.
Reimann, H. A. (1948). Periodic disease; a probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia and intermittent arthralgia. Journal of the American Medical Association, 136, 239–244.
de Sarrauste, M. C., Terriere, S., Pugnere, D., Ruiz, M., Demaille, J., & Touitou, I. (2003). INFEVERS: The Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Research, 31, 282–285.
Schlesinger, N., Alten, R. E., Bardin, T., Schumacher, H. R., Bloch, M., Gimona, A., et al. (2012). Canakinumab for acute gouty arthritis in patients with limited treatment options: Results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Annals of the Rheumatic Diseases, 71, 1839–1848.
Seshadri, S., Duncan, M. D., Hart, J. M., Gavrilin, M. A., & Wewers, M. D. (2007). Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release. Journal of Immunology, 179, 1274–1281.
Shinkai, K., Kilcline, C., Connolly, M. K., & Frieden, I. J. (2005). The pyrin family of fever genes: Unmasking genetic determinants of autoinflammatory disease. Archives of Dermatology, 141, 242–247.
Shohat, M., & Halpern, G. J. (2011). Familial Mediterranean fever – A review. Genetics in Medicine, 13, 487–498.
Simon, A., Cuisset, L., Vincent, M. F., van Der Velde-Visser, S. D., Delpech, M., van Der Meer, J. W., et al. (2001). Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: Its application as a diagnostic tool. Annals of Internal Medicine, 135, 338–343.
Simonini, G., Xu, Z., Caputo, R., De, L. C., Pagnini, I., Pascual, V., et al. (2013). Clinical and transcriptomic response to the long-acting IL-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis and Rheumatism, 65, 513–518.
Stojanov, S., Lapidus, S., Chitkara, P., Feder, H., Salazar, J. C., Fleisher, T. A., et al. (2011). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proceedings of the National academy of Sciences of the United States of America, 108, 7148–7153.
Taieb, A. (2007). NALP1 and the inflammasomes: Challenging our perception of vitiligo and vitiligo-related autoimmune disorders. Pigment Cell Research, 20, 260–262.
ter Haar, N., Lachmann, H., Ozen, S., Woo, P., Uziel, Y., Modesto, C., et al. (2012). Treatment of autoinflammatory diseases: Results from the Eurofever Registry and a literature review. Annals of the Rheumatic Diseases, 72, 678–685.
Touitou, I., Sarrauste de, M.C., Milhavet, F. (2012). Infevers: An online database for autoinflammatory mutations. Retrieved 20 Dec 2012, from http://fmf.igh.cnrs.fr/ISSAID/infevers/
Touitou, I., Lesage, S., McDermott, M., Cuisset, L., Hoffman, H., Dode, C., et al. (2004). Infevers: An evolving mutation database for auto-inflammatory syndromes. Human Mutation, 24, 194–198.
van der Hilst, J. C., Bodar, E. J., Barron, K. S., Frenkel, J., Drenth, J. P., van Der Meer, J. W., et al. (2008). Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore), 87, 301–310.
Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., et al. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Medicine, 17, 179–188.
Wilson, S. P., & Cassel, S. L. (2010). Inflammasome-mediated autoinflammatory disorders. Postgraduate Medicine, 122, 125–133.
Wurster, V. M., Carlucci, J. G., Feder, H. M., Jr., & Edwards, K. M. (2011). Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. Journal of Pediatrics, 159, 958–964.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Basel
About this entry
Cite this entry
Ward, B.R. (2015). Autoinflammatory Syndromes. In: Parnham, M. (eds) Encyclopedia of Inflammatory Diseases. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-0620-6_188-3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0620-6_188-3
Received:
Accepted:
Published:
Publisher Name: Birkhäuser, Basel
Online ISBN: 978-3-0348-0620-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences